507 related articles for article (PubMed ID: 26734709)
1. Epigenetic Alterations in Alzheimer's Disease.
Sanchez-Mut JV; Gräff J
Front Behav Neurosci; 2015; 9():347. PubMed ID: 26734709
[TBL] [Abstract][Full Text] [Related]
2. Neuroepigenetics and Alzheimer's Disease: An Update.
Zusso M; Barbierato M; Facci L; Skaper SD; Giusti P
J Alzheimers Dis; 2018; 64(3):671-688. PubMed ID: 29991138
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics in Alzheimer's Disease: Perspective of DNA Methylation.
Qazi TJ; Quan Z; Mir A; Qing H
Mol Neurobiol; 2018 Feb; 55(2):1026-1044. PubMed ID: 28092081
[TBL] [Abstract][Full Text] [Related]
4. Restoring Tip60 HAT/HDAC2 Balance in the Neurodegenerative Brain Relieves Epigenetic Transcriptional Repression and Reinstates Cognition.
Panikker P; Xu SJ; Zhang H; Sarthi J; Beaver M; Sheth A; Akhter S; Elefant F
J Neurosci; 2018 May; 38(19):4569-4583. PubMed ID: 29654189
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics: Recent Advances and Its Role in the Treatment of Alzheimer's Disease.
Xiao X; Liu X; Jiao B
Front Neurol; 2020; 11():538301. PubMed ID: 33178099
[No Abstract] [Full Text] [Related]
6. Epigenetic mechanisms in Alzheimer's disease.
Daniilidou M; Koutroumani M; Tsolaki M
Curr Med Chem; 2011; 18(12):1751-6. PubMed ID: 21466476
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Modifications in Alzheimer's Neuropathology and Therapeutics.
Esposito M; Sherr GL
Front Neurosci; 2019; 13():476. PubMed ID: 31133796
[TBL] [Abstract][Full Text] [Related]
8. Epigenetically regulated microRNAs in Alzheimer's disease.
Van den Hove DL; Kompotis K; Lardenoije R; Kenis G; Mill J; Steinbusch HW; Lesch KP; Fitzsimons CP; De Strooper B; Rutten BP
Neurobiol Aging; 2014 Apr; 35(4):731-45. PubMed ID: 24238656
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy.
Wang J; Yu JT; Tan MS; Jiang T; Tan L
Ageing Res Rev; 2013 Sep; 12(4):1024-41. PubMed ID: 23688931
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic drugs in Alzheimer's disease.
Cuadrado-Tejedor M; Oyarzabal J; Lucas MP; Franco R; García-Osta A
Biomol Concepts; 2013 Oct; 4(5):433-45. PubMed ID: 25436752
[TBL] [Abstract][Full Text] [Related]
11. Roles of the MYST Family in the Pathogenesis of Alzheimer's Disease via Histone or Non-histone Acetylation.
Li Y; Huang H; Zhu M; Bai H; Huang X
Aging Dis; 2021 Feb; 12(1):132-142. PubMed ID: 33532133
[TBL] [Abstract][Full Text] [Related]
12. Neuroepigenetics of ageing and neurodegeneration-associated dementia: An updated review.
Mir FA; Amanullah A; Jain BP; Hyderi Z; Gautam A
Ageing Res Rev; 2023 Nov; 91():102067. PubMed ID: 37689143
[TBL] [Abstract][Full Text] [Related]
13. The Epigenetics of Alzheimer's Disease: Factors and Therapeutic Implications.
Liu X; Jiao B; Shen L
Front Genet; 2018; 9():579. PubMed ID: 30555513
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Alterations in Alzheimer's Disease: Impact on Insulin Signaling and Advanced Drug Delivery Systems.
Greeny A; Nair A; Sadanandan P; Satarker S; Famurewa AC; Nampoothiri M
Biology (Basel); 2024 Feb; 13(3):. PubMed ID: 38534427
[TBL] [Abstract][Full Text] [Related]
15. Impaired mitochondrial energy metabolism in Alzheimer's disease: Impact on pathogenesis via disturbed epigenetic regulation of chromatin landscape.
Salminen A; Haapasalo A; Kauppinen A; Kaarniranta K; Soininen H; Hiltunen M
Prog Neurobiol; 2015 Aug; 131():1-20. PubMed ID: 26001589
[TBL] [Abstract][Full Text] [Related]
16. Recent studies on cellular and molecular mechanisms in Alzheimer's disease: focus on epigenetic factors and histone deacetylase.
Dubey H; Gulati K; Ray A
Rev Neurosci; 2018 Mar; 29(3):241-260. PubMed ID: 29397389
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders.
Delgado-Morales R; Agís-Balboa RC; Esteller M; Berdasco M
Clin Epigenetics; 2017; 9():67. PubMed ID: 28670349
[TBL] [Abstract][Full Text] [Related]
18. The Contribution and Therapeutic Potential of Epigenetic Modifications in Alzheimer's Disease.
Wood IC
Front Neurosci; 2018; 12():649. PubMed ID: 30283297
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders.
Konsoula Z; Barile FA
J Pharmacol Toxicol Methods; 2012; 66(3):215-20. PubMed ID: 22902970
[TBL] [Abstract][Full Text] [Related]
20. Imaging epigenetics in Alzheimer's disease.
Lista S; Garaci FG; Toschi N; Hampel H
Curr Pharm Des; 2013; 19(36):6393-415. PubMed ID: 23432717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
